# Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia

> **NCT05505539** · PHASE1 · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Oral Leukoplakia

## Interventions

- **DRUG:** 5-fluorouracil

## Key facts

- **NCT ID:** NCT05505539
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-09-30
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Principal Investigator no longer with university.
- **Last updated:** 2022-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05505539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05505539, "Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT05505539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*